gastrointestinal microbiota
http://www.yso.fi/onto/yso/p37925
Related publications and other outputs
1 of 4
- Fecal Metagenomics and Metabolomics Identifying Microbial Signatures in Non-Alcoholic Fatty Liver Disease (2023) Pekkala, Satu; A1; OA
- Gut microbiome and atrial fibrillation : results from a large population-based study (2023) Palmu, Joonatan; et al.; A1; OA
- Gut microbiota alterations after switching from a protease inhibitor or efavirenz to raltegravir in a randomized, controlled study (2023) Hanttu, Anna M.; et al.; A1
- Identification of Gut Microbial Lysine and Histidine Degradation and CYP-Dependent Metabolites as Biomarkers of Fatty Liver Disease (2023) Driuchina, Anastasiia; et al.; A1; OA
- Idiosyncratic effects of coinfection on the association between systemic pathogens and the gut microbiota of a wild rodent, the bank vole Myodes glareolus (2023) Brila, Ilze; et al.; A1
- A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease (2022) Cheng, Runtan; et al.; A1; OA
- Complex plant quality—microbiota–population interactions modulate the response of a specialist herbivore to the defence of its host plant (2022) Minard, Guillaume; et al.; A1; OA
- Evolved high aerobic capacity has context-specific effects on gut microbiota (2022) Hanhimäki, Elina; et al.; A1; OA
- Gut Microbiota and Serum Metabolome in Elite Cross-Country Skiers : A Controlled Study (2022) Hintikka, Jukka E.; et al.; A1; OA
- Interpretation of gut microbiota data in the ‘eye of the beholder’ : A commentary and re‐evaluation of data from ‘Impacts of radiation exposure on the bacterial and fungal microbiome of small mammals in the Chernobyl Exclusion Zone’ (2022) Watts, Phillip C.; et al.; A1; OA
